Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 1990 June; 34(6): 1227–1231.
PMCID: PMC171789

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.


The clinical courses of 13 consecutive intravenous drug users with Staphylococcus aureus endocarditis treated principally with vancomycin were reviewed. Two patients, one with only right-sided endocarditis and the other with tricuspid and mitral valve endocarditis, had recurrences of positive blood cultures 2 days after completing a 4-week course of vancomycin. Two patients, both of whom eventually were cured, had modifications of therapy because of bacteremia persisting 7 and 16 days into therapy. One patient required an operation for recurrent fevers, and the resected vegetation showed evidence of active infection. Time-kill studies performed with nafcillin and vancomycin for 10 isolates of S. aureus showed that vancomycin was less rapidly bactericidal than nafcillin. Although vancomycin is used as an alternative to penicillinase-resistant penicillins for treatment of staphylococcal endocarditis, these findings raise the question of whether it is equivalent to these drugs in efficacy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (943K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abrams B, Sklaver A, Hoffman T, Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med. 1979 May;90(5):789–791. [PubMed]
  • Barg NL, Supena RB, Fekety R. Persistent staphylococcal bacteremia in an intravenous drug abuser. Antimicrob Agents Chemother. 1986 Feb;29(2):209–211. [PMC free article] [PubMed]
  • Bayer AS. Staphylococcal bacteremia and endocarditis: state of the art. Arch Intern Med. 1982 Jun;142(6):1169–1177. [PubMed]
  • Cafferkey MT, Hone R, Keane CT. Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1985 Dec;28(6):819–823. [PMC free article] [PubMed]
  • Cantoni L, Wenger A, Glauser MP, Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis. 1989 May;159(5):989–993. [PubMed]
  • Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988 Oct 15;109(8):619–624. [PubMed]
  • Cooper RH, Savitch CB, Joseph WP, Mills J. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother. 1981 Feb;19(2):256–259. [PMC free article] [PubMed]
  • Faville RJ, Jr, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA. 1978 Oct 27;240(18):1963–1965. [PubMed]
  • Garaud JJ, Regnier B, Lassoued K, Pangon B, Leport C. Traitement des staphylococcies graves. Echecs de la rifampicine en association. Quatre observations. Presse Med. 1985 May 4;14(18):1013–1016. [PubMed]
  • Geiseler PJ, Rice TW, McCulley DJ, Lewis SM, Berzins BL. Failure of medical therapy in tricuspid endocarditis due to Staphylococcus aureus. Chemotherapy. 1984;30(6):408–412. [PubMed]
  • Geraci JE, Wilson WR. Vancomycin therapy for infective endocarditis. Rev Infect Dis. 1981 Nov-Dec;3 Suppl:S250–S258. [PubMed]
  • Gopal V, Bisno AL, Silverblatt FJ. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed]
  • Greenman RL, Arcey SM, Gutterman DA, Zweig RM. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Antimicrob Agents Chemother. 1984 Jan;25(1):16–19. [PMC free article] [PubMed]
  • Karchmer AW. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. [PubMed]
  • Klastersky J, Coppens L, van der Auwera P, Meunier-Carpentier F. Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections. J Antimicrob Chemother. 1983 Apr;11(4):361–367. [PubMed]
  • Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med. 1982 Oct;97(4):496–503. [PubMed]
  • Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med. 1982 Sep;97(3):330–338. [PubMed]
  • Massanari RM, Donta ST. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest. 1978 Mar;73(3):371–375. [PubMed]
  • Menda KB, Gorbach SL. Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med. 1973 Jan;78(1):25–32. [PubMed]
  • Milatovic D. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? Eur J Clin Microbiol. 1986 Dec;5(6):689–692. [PubMed]
  • Parker RH, Fossieck BE., Jr Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. Ann Intern Med. 1980 Dec;93(6):832–834. [PubMed]
  • Rajashekaraiah KR, Rice T, Rao VS, Marsh D, Ramakrishna B, Kallick CA. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med. 1980 Dec;93(6):796–801. [PubMed]
  • Sklaver AR, Hoffman TA, Greenman RL. Staphylococcal endocarditis in addicts. South Med J. 1978 Jun;71(6):638–643. [PubMed]
  • Sorrell TC, Packham DR, Shanker S, Foldes M, Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. [PubMed]
  • Tuazon CU, Cardella TA, Sheagren JN. Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med. 1975 Dec;135(12):1555–1561. [PubMed]
  • Weinstein MP, Stratton CW, Ackley A, Hawley HB, Robinson PA, Fisher BD, Alcid DV, Stephens DS, Reller LB. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med. 1985 Feb;78(2):262–269. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)